CEO Mireille Gingras says Huya Bioscience is capitalizing on the growth of the Chinese biopharma industry.

CEO Mireille Gingras says Huya Bioscience is capitalizing on the growth of the Chinese biopharma industry.

— Convinced the future of drug development will rely as much on local innovation as overseas support, leaders of some San Diego County life sciences companies said they’re forging stronger ties with China than ever before...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129